Ali Çağır

785 total citations
28 papers, 662 citations indexed

About

Ali Çağır is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ali Çağır has authored 28 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Ali Çağır's work include Cancer therapeutics and mechanisms (6 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and biological activity (5 papers). Ali Çağır is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and biological activity (5 papers). Ali Çağır collaborates with scholars based in Türkiye, United States and Palestinian Territory. Ali Çağır's co-authors include Sidney M. Hecht, Rong Gao, Brian M. Eisenhauer, Shannon H. Jones, Ahmet E. Eroğlu, T. Shahwan, Ezel Boyacı, Pınar Kasaplar, Mustafa M. Demir and Ümit Hakan Yıldız and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Engineering Journal and The Journal of Physical Chemistry C.

In The Last Decade

Ali Çağır

28 papers receiving 649 citations

Peers

Countries citing papers authored by Ali Çağır

Since Specialization

Citations

This map shows the geographic impact of Ali Çağır's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Çağır with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Çağır more than expected).

Fields of papers citing papers by Ali Çağır

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Çağır. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Çağır. The network helps show where Ali Çağır may publish in the future.

Co-authorship network of co-authors of Ali Çağır

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Çağır. A scholar is included among the top collaborators of Ali Çağır based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Çağır. Ali Çağır is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Speciation of inorganic and organometallic arsenic in various matrices with a novel SPME fiber functionalized with iron nanoparticles prior to LC-ICP-MS determination 2025 ·Talanta ·Ezel Boyacı, Ali Çağır, T. Shahwan, Ahmet E. Eroğlu	1
2	Comprehensive Analysis of Lutein and Loroxanthin in Scenedesmus obliquus: From Quantification to Isolation 2024 ·Molecules ·Ayşegül Erdoğan, (unknown), (unknown), Zeliha Demirel, (unknown), (unknown), Ali Çağır, Meltem Conk Dalay	3
3	Astragalus Saponins, Astragaloside VII and Newly Synthesized Derivatives, Induce Dendritic Cell Maturation and T Cell Activation 2023 ·Vaccines ·(unknown), Ali Çağır, Erdal Bedi̇r, Duygu Sağ	4
4	Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo 2021 ·ACS Pharmacology & Translational Science ·Ferah Cömert Önder, Nermin Kahraman, Esen Bellur Atıcı, Ali Çağır, Hakan Kandemir, Gizem Tatar, Tuğba Taşkın‐Tok, Göknur Kara, (unknown), Serdar Durdağı, Mehmet Ay, Bülent Özpolat	13
5	Correction to “Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo” 2021 ·ACS Pharmacology & Translational Science ·Ferah Cömert Önder, Nermin Kahraman, Esen Bellur Atıcı, Ali Çağır, Hakan Kandemir, Gizem Tatar, Tuğba Taşkın‐Tok, Göknur Kara, (unknown), Serdar Durdağı, Mehmet Ay, Bülent Özpolat	2
6	Novel 2′-alkoxymethyl substituted klavuzon derivatives as inhibitors of Topo I and CRM1 2020 ·Bioorganic Chemistry ·Hakkı Çetinkaya, (unknown), (unknown), (unknown), (unknown), Ali Çağır	1
7	A new drug testing platform based on 3D tri-culture in lab-on-a-chip devices 2020 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), Ali Çağır, Devrim Pesen‐Okvur	9
8	Antiproliferative activity of (R)-4′-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition 2019 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Esra Erdal, Ali Çağır	13
9	Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones 2017 ·Anti-Cancer Agents in Medicinal Chemistry ·Ali Çağır, (unknown), Mehmet Varol, (unknown), (unknown), Ayşe Tansu Koparal	3
10	CRM1 inhibitory and antiproliferative activities of novel 4′-alkyl substituted klavuzon derivatives 2017 ·Bioorganic & Medicinal Chemistry ·(unknown), Murat Kara, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ali Çağır	8
11	Synthesis and Topoisomerase I inhibitory properties of klavuzon derivatives 2017 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), Pınar Kasaplar, Kemal Korkmaz, Ali Çağır	7
12	Synthesis, characterization and application of a novel mercapto- and amine-bifunctionalized silica for speciation/sorption of inorganic arsenic prior to inductively coupled plasma mass spectrometric determination 2011 ·Talanta ·Ezel Boyacı, Ali Çağır, T. Shahwan, Ahmet E. Eroğlu	42
13	Deglycobleomycin A6 analogues modified in the methylvalerate moiety 2011 ·Bioorganic & Medicinal Chemistry ·Xiaoqing Cai, (unknown), Ali Çağır, Sidney M. Hecht	5
14	Michael acceptor properties of 6-bicycloaryl substituted (R)-5,6-dihydro-2H-pyran-2-ones 2010 ·Bioorganic Chemistry ·Pınar Kasaplar, (unknown), Ali Çağır	7
15	Synthesis of stilbene-fused 2′-hydroxychalcones and flavanones 2010 ·Bioorganic Chemistry ·(unknown), Ali Çağır	17
16	6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: Asymmetric synthesis, and anti-proliferative properties 2008 ·Bioorganic & Medicinal Chemistry ·Pınar Kasaplar, (unknown), Ali Çağır	27
17	Synthesis and topoisomerase I inhibitory properties of luotonin A analogues 2004 ·Bioorganic & Medicinal Chemistry ·Ali Çağır, Brian M. Eisenhauer, Rong Gao, (unknown), Sidney M. Hecht	59
18	Synthesis and biochemical properties of E-ring modified luotonin A derivatives 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ali Çağır, Shannon H. Jones, Brian M. Eisenhauer, Rong Gao, Sidney M. Hecht	43
19	Solid-phase synthesis and biochemical evaluation of conformationally constrained analogues of deglycobleomycin A 5 2003 ·Bioorganic & Medicinal Chemistry ·Ali Çağır, (unknown), Steven J. Sucheck, Sidney M. Hecht	4
20	Novel enantioselective synthesis of trans-α-(2-carboxycycloprop-1-yl)glycines: conformationally constrained l-glutamate analogues 1998 ·Tetrahedron Asymmetry ·Ayhan S. Demir, Cihangir Tanyeli, Ali Çağır, Muhammad Nawaz Tahir, D. Ülkü	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact